Drugs developed for the treatment of diabetes show protective effects in Alzheimers and Parkinsons diseases
This ensures direct absorption into your bloodstream for maximum effectiveness
Days 2 and 3: Take 2 capsules once a day
Our all products are DRAP (Drug Regulatory Authority of Pakistan) enlisted and manufactured under Current Good Manufacturing Practices (cGMPs), ensuring that they are manufactured to high standards of potency, purity, efficacy, and safety
#DiabetesCare #PrecisionMedicine #MetabolicHealth #LowerTheDose #HealthcareInnovation To view or add a comment, sign in In our recent publication in Diabetes, Obesity and Metabolism, together with Professors Kokkinos and le Roux, we articulate a perspective grounded in robust scientific evidence, yet one that is rarely expressed with candor in the public scientific discourse: that, as with any other chronic disease, pharmacotherapy should constitute the central pillar in the treatment of obesity, while other approaches retain an important but complementary role
People with T2D experience worsening glycaemic control and the development of complications over time [1, 2]